Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TELA
TELA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TELA News
TELA Bio Reports Q4 2025 Earnings with Strategic Changes
6d ago
seekingalpha
TELA Bio (TELA) Q4 2025 Earnings Call Transcript
6d ago
NASDAQ.COM
TELA Biopress Q4 Financial Results Analysis
6d ago
seekingalpha
TELA BIO INC - Q4 REVENUE REACHED $20.9 MILLION
6d ago
moomoo
TELA BIO PROJECTS REVENUE OF APPROXIMATELY $18.5 MILLION FOR Q1 2026
6d ago
moomoo
TELA BIO PROJECTS AT LEAST 8% REVENUE GROWTH FOR FULL YEAR 2026 COMPARED TO 2025
6d ago
moomoo
BDX Faces Monopoly Allegations in U.S. Hernia Mesh Market, Impacting Patient Choices
Dec 23 2025
Benzinga
Becton, Dickinson Faces Allegations of Stifling Competition in Hernia Mesh Industry
Dec 22 2025
SeekingAlpha
TELA Bio Grants 3,600 Restricted Stock Units to New Employees
Dec 12 2025
Globenewswire
TELA Bio Grants 3,600 Restricted Stock Units to New Employees
Dec 12 2025
Newsfilter
Alphabet Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Tuesday
Nov 18 2025
Benzinga
Canaccord Genuity Keeps Buy Rating on TELA Bio, Reduces Price Target to $4
Nov 18 2025
Benzinga
NOTV and APLT Top After-Hours Biotech Gains; ALMS, TELA, CORT, and BRTX Also Show Progress
Nov 18 2025
NASDAQ.COM
TELA Bio Unveils Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
Nov 17 2025
Newsfilter
Analysts Downgrade TELA Bio Forecasts Following Q3 Earnings Report
Nov 14 2025
Benzinga
Piper Sandler Maintains Neutral Rating on TELA Bio, Reduces Price Target to $1.25
Nov 14 2025
Benzinga
Show More News
